YUCAIPA, Calif., Jan. 7, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:ITEC), an emerging medical device manufacturer of the new Oxyview and OxyAlert product announced today that it has hired Dr. Lee Hoffman to head-up the new marketing program that will target 10,000+ pulmonologists in the U.S.
The company has hired Dr. Lee Hoffman to manage and target a marketing campaign that would introduce Oxyview and OxyAlert to pulmonologists in North America. "The pulmonologist is the gate-keeper for all patients who have been diagnosed with Chronic Obstructive Pulmonary Disease. The Pulmonologist prescribes all treatment and oversees all evaluations of their patients. We have successfully recruited several pulmonary clinics to prescribe Oxyview for their patients. The oxygen service providers and respiratory therapists have cooperated with the prescription requests as a part of their client relationship with the pulmonologist," stated Dr. Hoffman.
Babcock Medical Associates, P.A. in San Antonio, Texas is a leading pulmonology clinic in their area. Pam Weatherford, Office Manager, has informed Ingen that Oxyview is a "standing-order" with all of their oxygen patients. All local oxygen service providers and respiratory therapists are instructed to assure that all patient referrals from Babcock Medical receive an Oxyview. "This is an important breakthrough for Oxyview. The pulmonologist is more astute to their patient needs, and has the authority to assure that their patients receive the best possible care available. Oxyview enhances and improves patient care during oxygen therapy," stated Chris Wirth, COO of Ingen.
With more than 10,000 pulmonologists in the U.S. managing over 32 million COPD patients, the new marketing program will target all of the pulmonologists. The potential Oxyview sales in the first 6 months should represent 1% of the market, or about 322,000 patients. Oxyview sells for $24.95.
For more information please visit:
http://www.youtube.com/user/IngenTechnologies
About Ingen Technologies, Inc.
Ingen is an emerging public company (Pink Sheets:ITEC), registered and licensed by the FDA/DHS. The company introduced Oxyview(r) into the respiratory market in late 2007; the world's first in-line oxygen flow meter. The company continues to expand distribution of its flow meters to other industries thus increasing the potential for wide sources of revenue. These industries include medical, aviation, automotive, emergency response, military and government transportation.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.